Back
ESC Premium Access

Time to event analysis in patients managed on rivaroxaban while taking concurrent interacting medications (CIM)

Session: Poster Session 1 - Antiplatelet and anticoagulant drugs
Topic: Anticoagulants
Speaker: Doctor J. Michel (Austin, US)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Jeffrey Michel

Baylor Scott and White Health, Austin (United States of America)
0 follower

5 more presentations in this session

Aspirin resistance in patients with stable coronary heart disease

Speaker: Doctor T. Petroni (Montauban, FR)

Access
Abstract
Like
Thumbnail

CYP2C19-dependent clopidogrel resistance is a possible cause for coronary stent and peripheral bypass occlusion

Speaker: Assistant Professor M. Klinceva (Skopje, MK)

Access
Abstract
Slides
Like
Thumbnail

Fourier-spectroscopy capacity in assessment of resistance to acetylsalicylic acid in patients with stable angina pectoris

Speaker: Mrs A. Kosinova (Krasnoyarsk, RU)

Access
Abstract
Slides
Like
Thumbnail

Residual risk following myocardial infarction despite intensive medical management

Speaker: Professor R. Rosenson (New York, US)

Access
Abstract
Slides
Like
Thumbnail

Role of rivaroxaban in left ventricular thrombi

Speaker: Doctor A. Almaghraby (Ras Al Khaimah, AE)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 1 - Antiplatelet and anticoagulant drugs

Speakers: Doctor J. Michel, Doctor T. Petroni, Assistant Professor M. Klinceva, Mrs A. Kosinova, Professor R. Rosenson...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources